Collaborative Drug Therapy Management by Pharmacists
1997; Wiley; Volume: 17; Issue: 5 Linguagem: Inglês
10.1002/j.1875-9114.1997.tb03804.x
ISSN1875-9114
AutoresJannet M. Carmichael, Mary Beth O’Connell, Beth Devine, H. William Kelly, Larry Ereshefsky, William D. Linn, Glen L. Stimmel,
Tópico(s)Pharmacy and Medical Practices
ResumoPharmacotherapy: The Journal of Human Pharmacology and Drug TherapyVolume 17, Issue 5 p. 1050-1061 Free Access Collaborative Drug Therapy Management by Pharmacists Jannet M. Carmichael Pharm.D., FCCP, Corresponding Author Jannet M. Carmichael Pharm.D., FCCP This document was written by the following 1996–1997 ACCP Task Force on Prescriptive Authority: Jannet M. Carmichael, Pharm.D., FCCP, BCPS, Chair; Beth Devine, Pharm.D., BCPS; Larry Ereshefsky, Pharm.D., FCCP, BCPP; H. William Kelly, Pharm.D., FCCP, BCPS; Glen L. Stimmel, Pharm.D., FCCP; and Mary Beth O'Connell, Pharm.D., FCCP, FASHP, BCPS, Board Liaison. Staff editor: Peggy G. Kuehl, Pharm.D., BCPS. Approved by the ACCP Board of Regents on April 4, 1997.Address reprint requests to the American College of Clinical Pharmacy, 3101 Broadway, Suite 380, Kansas City, MO 64111; e-mail: [email protected].Search for more papers by this authorMary Beth O'Connell Pharm.D., FCCP, FASHP, Corresponding Author Mary Beth O'Connell Pharm.D., FCCP, FASHP This document was written by the following 1996–1997 ACCP Task Force on Prescriptive Authority: Jannet M. Carmichael, Pharm.D., FCCP, BCPS, Chair; Beth Devine, Pharm.D., BCPS; Larry Ereshefsky, Pharm.D., FCCP, BCPP; H. William Kelly, Pharm.D., FCCP, BCPS; Glen L. Stimmel, Pharm.D., FCCP; and Mary Beth O'Connell, Pharm.D., FCCP, FASHP, BCPS, Board Liaison. Staff editor: Peggy G. Kuehl, Pharm.D., BCPS. Approved by the ACCP Board of Regents on April 4, 1997.Address reprint requests to the American College of Clinical Pharmacy, 3101 Broadway, Suite 380, Kansas City, MO 64111; e-mail: [email protected].Search for more papers by this authorBeth Devine Pharm.D., Corresponding Author Beth Devine Pharm.D. This document was written by the following 1996–1997 ACCP Task Force on Prescriptive Authority: Jannet M. Carmichael, Pharm.D., FCCP, BCPS, Chair; Beth Devine, Pharm.D., BCPS; Larry Ereshefsky, Pharm.D., FCCP, BCPP; H. William Kelly, Pharm.D., FCCP, BCPS; Glen L. Stimmel, Pharm.D., FCCP; and Mary Beth O'Connell, Pharm.D., FCCP, FASHP, BCPS, Board Liaison. Staff editor: Peggy G. Kuehl, Pharm.D., BCPS. Approved by the ACCP Board of Regents on April 4, 1997.Address reprint requests to the American College of Clinical Pharmacy, 3101 Broadway, Suite 380, Kansas City, MO 64111; e-mail: [email protected].Search for more papers by this authorH. William Kelly Pharm.D., FCCP, Corresponding Author H. William Kelly Pharm.D., FCCP This document was written by the following 1996–1997 ACCP Task Force on Prescriptive Authority: Jannet M. Carmichael, Pharm.D., FCCP, BCPS, Chair; Beth Devine, Pharm.D., BCPS; Larry Ereshefsky, Pharm.D., FCCP, BCPP; H. William Kelly, Pharm.D., FCCP, BCPS; Glen L. Stimmel, Pharm.D., FCCP; and Mary Beth O'Connell, Pharm.D., FCCP, FASHP, BCPS, Board Liaison. Staff editor: Peggy G. Kuehl, Pharm.D., BCPS. Approved by the ACCP Board of Regents on April 4, 1997.Address reprint requests to the American College of Clinical Pharmacy, 3101 Broadway, Suite 380, Kansas City, MO 64111; e-mail: [email protected].Search for more papers by this authorLarry Ereshefsky Pharm.D., FCCP, Corresponding Author Larry Ereshefsky Pharm.D., FCCP This document was written by the following 1996–1997 ACCP Task Force on Prescriptive Authority: Jannet M. Carmichael, Pharm.D., FCCP, BCPS, Chair; Beth Devine, Pharm.D., BCPS; Larry Ereshefsky, Pharm.D., FCCP, BCPP; H. William Kelly, Pharm.D., FCCP, BCPS; Glen L. Stimmel, Pharm.D., FCCP; and Mary Beth O'Connell, Pharm.D., FCCP, FASHP, BCPS, Board Liaison. Staff editor: Peggy G. Kuehl, Pharm.D., BCPS. Approved by the ACCP Board of Regents on April 4, 1997.Address reprint requests to the American College of Clinical Pharmacy, 3101 Broadway, Suite 380, Kansas City, MO 64111; e-mail: [email protected].Search for more papers by this authorWilliam D. Linn Pharm.D., Corresponding Author William D. Linn Pharm.D. This document was written by the following 1996–1997 ACCP Task Force on Prescriptive Authority: Jannet M. Carmichael, Pharm.D., FCCP, BCPS, Chair; Beth Devine, Pharm.D., BCPS; Larry Ereshefsky, Pharm.D., FCCP, BCPP; H. William Kelly, Pharm.D., FCCP, BCPS; Glen L. Stimmel, Pharm.D., FCCP; and Mary Beth O'Connell, Pharm.D., FCCP, FASHP, BCPS, Board Liaison. Staff editor: Peggy G. Kuehl, Pharm.D., BCPS. Approved by the ACCP Board of Regents on April 4, 1997.Address reprint requests to the American College of Clinical Pharmacy, 3101 Broadway, Suite 380, Kansas City, MO 64111; e-mail: [email protected].Search for more papers by this authorGlen L. Stimmel Pharm.D., FCCP, Corresponding Author Glen L. Stimmel Pharm.D., FCCP This document was written by the following 1996–1997 ACCP Task Force on Prescriptive Authority: Jannet M. Carmichael, Pharm.D., FCCP, BCPS, Chair; Beth Devine, Pharm.D., BCPS; Larry Ereshefsky, Pharm.D., FCCP, BCPP; H. William Kelly, Pharm.D., FCCP, BCPS; Glen L. Stimmel, Pharm.D., FCCP; and Mary Beth O'Connell, Pharm.D., FCCP, FASHP, BCPS, Board Liaison. Staff editor: Peggy G. Kuehl, Pharm.D., BCPS. Approved by the ACCP Board of Regents on April 4, 1997.Address reprint requests to the American College of Clinical Pharmacy, 3101 Broadway, Suite 380, Kansas City, MO 64111; e-mail: [email protected].Search for more papers by this author Jannet M. Carmichael Pharm.D., FCCP, Corresponding Author Jannet M. Carmichael Pharm.D., FCCP This document was written by the following 1996–1997 ACCP Task Force on Prescriptive Authority: Jannet M. Carmichael, Pharm.D., FCCP, BCPS, Chair; Beth Devine, Pharm.D., BCPS; Larry Ereshefsky, Pharm.D., FCCP, BCPP; H. William Kelly, Pharm.D., FCCP, BCPS; Glen L. Stimmel, Pharm.D., FCCP; and Mary Beth O'Connell, Pharm.D., FCCP, FASHP, BCPS, Board Liaison. Staff editor: Peggy G. Kuehl, Pharm.D., BCPS. Approved by the ACCP Board of Regents on April 4, 1997.Address reprint requests to the American College of Clinical Pharmacy, 3101 Broadway, Suite 380, Kansas City, MO 64111; e-mail: [email protected].Search for more papers by this authorMary Beth O'Connell Pharm.D., FCCP, FASHP, Corresponding Author Mary Beth O'Connell Pharm.D., FCCP, FASHP This document was written by the following 1996–1997 ACCP Task Force on Prescriptive Authority: Jannet M. Carmichael, Pharm.D., FCCP, BCPS, Chair; Beth Devine, Pharm.D., BCPS; Larry Ereshefsky, Pharm.D., FCCP, BCPP; H. William Kelly, Pharm.D., FCCP, BCPS; Glen L. Stimmel, Pharm.D., FCCP; and Mary Beth O'Connell, Pharm.D., FCCP, FASHP, BCPS, Board Liaison. Staff editor: Peggy G. Kuehl, Pharm.D., BCPS. Approved by the ACCP Board of Regents on April 4, 1997.Address reprint requests to the American College of Clinical Pharmacy, 3101 Broadway, Suite 380, Kansas City, MO 64111; e-mail: [email protected].Search for more papers by this authorBeth Devine Pharm.D., Corresponding Author Beth Devine Pharm.D. This document was written by the following 1996–1997 ACCP Task Force on Prescriptive Authority: Jannet M. Carmichael, Pharm.D., FCCP, BCPS, Chair; Beth Devine, Pharm.D., BCPS; Larry Ereshefsky, Pharm.D., FCCP, BCPP; H. William Kelly, Pharm.D., FCCP, BCPS; Glen L. Stimmel, Pharm.D., FCCP; and Mary Beth O'Connell, Pharm.D., FCCP, FASHP, BCPS, Board Liaison. Staff editor: Peggy G. Kuehl, Pharm.D., BCPS. Approved by the ACCP Board of Regents on April 4, 1997.Address reprint requests to the American College of Clinical Pharmacy, 3101 Broadway, Suite 380, Kansas City, MO 64111; e-mail: [email protected].Search for more papers by this authorH. William Kelly Pharm.D., FCCP, Corresponding Author H. William Kelly Pharm.D., FCCP This document was written by the following 1996–1997 ACCP Task Force on Prescriptive Authority: Jannet M. Carmichael, Pharm.D., FCCP, BCPS, Chair; Beth Devine, Pharm.D., BCPS; Larry Ereshefsky, Pharm.D., FCCP, BCPP; H. William Kelly, Pharm.D., FCCP, BCPS; Glen L. Stimmel, Pharm.D., FCCP; and Mary Beth O'Connell, Pharm.D., FCCP, FASHP, BCPS, Board Liaison. Staff editor: Peggy G. Kuehl, Pharm.D., BCPS. Approved by the ACCP Board of Regents on April 4, 1997.Address reprint requests to the American College of Clinical Pharmacy, 3101 Broadway, Suite 380, Kansas City, MO 64111; e-mail: [email protected].Search for more papers by this authorLarry Ereshefsky Pharm.D., FCCP, Corresponding Author Larry Ereshefsky Pharm.D., FCCP This document was written by the following 1996–1997 ACCP Task Force on Prescriptive Authority: Jannet M. Carmichael, Pharm.D., FCCP, BCPS, Chair; Beth Devine, Pharm.D., BCPS; Larry Ereshefsky, Pharm.D., FCCP, BCPP; H. William Kelly, Pharm.D., FCCP, BCPS; Glen L. Stimmel, Pharm.D., FCCP; and Mary Beth O'Connell, Pharm.D., FCCP, FASHP, BCPS, Board Liaison. Staff editor: Peggy G. Kuehl, Pharm.D., BCPS. Approved by the ACCP Board of Regents on April 4, 1997.Address reprint requests to the American College of Clinical Pharmacy, 3101 Broadway, Suite 380, Kansas City, MO 64111; e-mail: [email protected].Search for more papers by this authorWilliam D. Linn Pharm.D., Corresponding Author William D. Linn Pharm.D. This document was written by the following 1996–1997 ACCP Task Force on Prescriptive Authority: Jannet M. Carmichael, Pharm.D., FCCP, BCPS, Chair; Beth Devine, Pharm.D., BCPS; Larry Ereshefsky, Pharm.D., FCCP, BCPP; H. William Kelly, Pharm.D., FCCP, BCPS; Glen L. Stimmel, Pharm.D., FCCP; and Mary Beth O'Connell, Pharm.D., FCCP, FASHP, BCPS, Board Liaison. Staff editor: Peggy G. Kuehl, Pharm.D., BCPS. Approved by the ACCP Board of Regents on April 4, 1997.Address reprint requests to the American College of Clinical Pharmacy, 3101 Broadway, Suite 380, Kansas City, MO 64111; e-mail: [email protected].Search for more papers by this authorGlen L. Stimmel Pharm.D., FCCP, Corresponding Author Glen L. Stimmel Pharm.D., FCCP This document was written by the following 1996–1997 ACCP Task Force on Prescriptive Authority: Jannet M. Carmichael, Pharm.D., FCCP, BCPS, Chair; Beth Devine, Pharm.D., BCPS; Larry Ereshefsky, Pharm.D., FCCP, BCPP; H. William Kelly, Pharm.D., FCCP, BCPS; Glen L. Stimmel, Pharm.D., FCCP; and Mary Beth O'Connell, Pharm.D., FCCP, FASHP, BCPS, Board Liaison. Staff editor: Peggy G. Kuehl, Pharm.D., BCPS. Approved by the ACCP Board of Regents on April 4, 1997.Address reprint requests to the American College of Clinical Pharmacy, 3101 Broadway, Suite 380, Kansas City, MO 64111; e-mail: [email protected].Search for more papers by this author First published: 17 January 2012 https://doi.org/10.1002/j.1875-9114.1997.tb03804.xCitations: 15 AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Webb EC. Prescribing medications: changing the paradigm for a changing health care system. Am J Health-Syst Pharm 1995; 52: 1693–5. 2 Marks HM. Revisiting "the origins of compulsory drug prescriptions." Am J Public Health 1995; 85: 109–15. 3 Swann JP. FDA and the practice of pharmacy: prescription drug regulation before the Durham-Humphrey amendment of 1951. Pharmacy in History 1994; 36: 55–70. 4 Brands AJ. Treating ambulatory patients. U.S. Pharmacist 1977; 2: 70–4. 5 Erickson SH. Primary care by a pharmacist in an outpatient clinic. Am J Hosp Pharm 1977; 34: 1086. 6 Health Manpower Pilot Projects. Final report to the legislature, state of California and to the Healing Arts Licensing Boards. Prescribing and dispensing pilot projects. Office of Statewide Health Planning and Development, Division of Health Professions Development. November 1982. 7 An interview with Gordon Duffy, Assemblyman, 32nd District. CSHP Voice. 1978: 5; 11. 8 California Assembly Bill 1868, 1981. 9 California Senate Bill 502, 1983. 10 California Assembly Bill 1759, 1994. 11 Thompson JF, McGhan WF, Ruffalo RL, Cohen DA, Adamcik B, Segal JL. Clinical pharmacists prescribing drug therapy in a geriatric setting: outcome of a trial. J Am Geriatr Soc 1984; 32: 154–9. 12 Christensen D, Fuller T, Williams D. Prescriptive authority protocols. 1993 Washington state survey. Washington State Board of Pharmacy, 1993. 13 Christensen D. Prescriptive authority for pharmacists: current status and future opportunities. Presented at the American Society of Hospital Pharmacists annual meeting, Reno, Nevada, June 59, 1994. 14 Flanagan ME. Update on state prescribing authority. Am Pharm 1995; NS35: 13–8. 15 Borgsdorf LR, Miano JS, Knapp KK. Pharmacist-managed medication review in a managed care system. Am J Hosp Pharm 1994; 51: 772–7. 16 Bjornson DC, Hiner WO, Potyk RP, et al. Effect of pharmacists on health care outcomes in hospitalized patients. Am J Hosp Pharm 1993; 50: 1875–84. 17 Chenella FC, Klotz TA, Gill MA, et al. Comparison of physician and pharmacist management of anticoagulant therapy of inpatients. Am J Hosp Pharm 1983; 40: 1642–5. 18 Conte RR. Training and activities of pharmacist prescribers in a California pilot project. Am J Hosp Pharm 1986; 43: 375–80. 19 Ellis RF, Stephens MA, Sharp GB. Evaluation of a pharmacy-managed warfarin-monitoring service to coordinate inpatient and outpatient therapy. Am J Hosp Pharm 1992; 49: 387–94. 20 Hawkins DW, Fiedler FP, Douglas HL, Eschbach RC. Evaluation of a clinical pharmacist in caring for hypertensive and diabetic patients. Am J Hosp Pharm 1979; 36: 1321–5. 21 Menard PJ, Kirshner BS, Kloth DD, Pyka RS, Hill LR, Venkataraman K. Management of the hypertensive patient by the pharmacist prescriber. Hosp Pharm 1986; 21: 20–35. 22 Stimmel GL, McGhan WF, Wincor MZ, Deandrea DM. Comparison of pharmacist and physician prescribing for psychiatric inpatients. Am J Hosp Pharm 1982; 39: 1483–6. 23 Schumock GT, Meek PD, Ploetz PA, Vermeulen LC, Publications Committee of the American College of Clinical Pharmacy. Economic evaluations of clinical pharmacy services-1988-1995. Pharmacotherapy 1996; 16(6): 1188–1208. 24 Pew Health Professions Commission. Critical challenges: revitalizing the health professions for the twenty-first century. San Francisco: UCSF Center for the Health Professions, 1995. 25 Schieber GS, Poullier JP, Greenwald LM. Health system performance in OECD countries, 1980–1992. Health Affairs 1994; 13: 100–12. 26 Holdford DA. Barriers to disease management. Am J Health-Syst Pharm 1996; 53: 2093–6. 27 Trinca CE. The pharmacist's progress toward implementing pharmaceutical care. Presented at The Third Strategic Planning Conference for Pharmacy Practice: Pharmacy in the 21st Century, Lansdowne, Virginia, October 710, 1994. 28 Carmichael J. Do pharmacists need prescribing privileges to implement pharmaceutical care? Am J Health-Syst Pharm 1995; 52: 699–701. 29 Galt KA. The key to pharmacist prescribing: collaboration. Am J Health-Syst Pharm 1995; 52: 1696–9. 30 American Council on Pharmaceutical Education. Accreditation standards and guidelines for the professional program in pharmacy leading to the Doctor of Pharmacy degree. Adopted June 14, 1997. Chicago: American Council on Pharmaceutical Education, Inc., 1997. 31 Oddis JA. Pharmacy in integrated health care systems. Am J Health-Syst Pharm 1996; 53(suppl l): Sl–49. 32 American College of Clinical Pharmacy. Establishing and evaluating clinical pharmacy services in primary care. Pharmacotherapy 1994; 14(6): 743–58. Citing Literature Volume17, Issue5September‐October 1997Pages 1050-1061 ReferencesRelatedInformation
Referência(s)